The involvement of endothelial mediators in leprosy

scientific article published on 03 October 2016

The involvement of endothelial mediators in leprosy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1590/0074-02760160122
P8608Fatcat IDrelease_6s55jv53sjathey2m2s2xmy5aq
P932PMC publication ID5066329
P698PubMed publication ID27706378

P2093author name stringMaria Esther Salles Nogueira
Ana Carla Pereira Latini
Maria Renata Sales Nogueira
P2860cites workThe continuing challenges of leprosyQ24545809
Unsolved matters in leprosy: a descriptive review and call for further researchQ26747134
Inflammatory Mediators of Leprosy Reactional Episodes and Dental Infections: A Systematic ReviewQ26785530
Potential plasma markers of Type 1 and Type 2 leprosy reactions: a preliminary reportQ33454062
Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2Q34195975
Classification of leprosy according to immunity. A five-group systemQ34242412
Vascular bed-specific hemostasis: role of endothelium in sepsis pathogenesisQ34303799
Endothelium: interface between coagulation and inflammationQ34633538
Differential gene expression in thrombomodulin (TM; CD141)(+) and TM(-) dendritic cell subsetsQ34979529
Angiogenesis and lymphangiogenesis in the spectrum of leprosy and its reactional formsQ34990214
Risk factors for leprosy reactions in three endemic countriesQ35140523
EPCR-dependent PAR2 activation by the blood coagulation initiation complex regulates LPS-triggered interferon responses in mice.Q35584261
Longitudinal immune profiles in type 1 leprosy reactions in Bangladesh, Brazil, Ethiopia and NepalQ35825015
Soluble thrombomodulin reduces inflammation and prevents microalbuminuria induced by chronic endothelial activation in transgenic miceQ35849496
The role of thrombomodulin lectin-like domain in inflammationQ35927779
IL-27 Suppresses Antimicrobial Activity in Human LeprosyQ36054382
Spatial and temporal dynamics of the endotheliumQ36126944
The integrin VLA-4 supports tethering and rolling in flow on VCAM-1.Q36235481
Multibacillary leprosy patients with high and persistent serum antibodies to leprosy IDRI diagnostic-1/LID-1: higher susceptibility to develop type 2 reactions.Q36321464
The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor kappaB and mitogen-activated protein kinase pathwaysQ36371054
Tissue factor expression by myeloid cells contributes to protective immune response against Mycobacterium tuberculosis infectionQ36540595
Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responsesQ36842908
Expression of adhesion molecules in leprosy lesionsQ36989208
Activation of VCAM-1 and its associated molecule CD44 leads to increased malignant potential of breast cancer cellsQ37683976
Biomarkers of endothelial activation/dysfunction in infectious diseasesQ37713182
Leprosy susceptibility: genetic variations regulate innate and adaptive immunity, and disease outcomeQ37876414
Endothelium--role in regulation of coagulation and inflammationQ37918456
New insights into pathways that determine the link between infection and thrombosis.Q38003802
New insights in the pathogenesis of type 1 and type 2 lepra reactionQ38157605
Protective and pathological roles of tissue factor in the heartQ38272797
Advances in leprosy immunology and the field application: A gap to bridgeQ38698605
E-selectin and P-selectin expression in endothelium of leprosy skin lesionsQ39481439
Leprosy type 1 reaction (formerly reversal reaction).Q40831216
Increased Langerhans cell accumulation after mycobacterial stimuliQ42072317
Longitudinal immune responses and gene expression profiles in type 1 leprosy reactionsQ42235469
Effects of human soluble thrombomodulin on experimental glomerulonephritisQ43889533
Markers of platelet, endothelial cell and blood coagulation activation in leprosy patients with antiphospholipid antibodies.Q44099584
Regulation of thrombomodulin expression in human vascular smooth muscle cells by COX-2-derived prostaglandinsQ45182845
Serum levels of thrombomodulin, intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin in the acute phase of Plasmodium vivax malariaQ47844306
Soluble adhesion molecules in sera of patients with leprosy: levels of soluble intercellular adhesion molecule-1 (sICAM-1) rapidly decrease during multi-drug therapy.Q51024385
Increased soluble vascular cell adhesion molecule 1 concentrations in patients with primary or systemic lupus erythematosus-related antiphospholipid syndrome: Correlations with the severity of thrombosisQ58622036
The VLA-4/VCAM-1 pathway is involved in lymphocyte adhesion to endothelium in rheumatoid synoviumQ67706705
Serum thrombomodulin. A novel marker of disease activity in systemic lupus erythematosusQ72340223
Cytokines: triggers of clinical thrombotic diseaseQ73447476
Overexpression of vascular endothelial growth factor and its endothelial cell receptor KDR in type 1 leprosy reactionQ74504043
Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivoQ77342565
Circulating levels of tissue factor and proinflammatory cytokines in patients with primary antiphospholipid syndrome or leprosy related antiphospholipid antibodiesQ81486591
Cyclooxygenase 2 expression in vessels and nerves in reversal reaction leprosyQ83947257
P433issue10
P921main subjectleprosyQ36956
endotheliumQ111140
P304page(s)635-641
P577publication date2016-10-03
P1433published inMemórias do Instituto Oswaldo CruzQ15760238
P1476titleThe involvement of endothelial mediators in leprosy
P478volume111

Reverse relations

cites work (P2860)
Q98735449Macrophage Polarization in Leprosy-HIV Co-infected Patients
Q51415628miRNome Expression Analysis Reveals New Players on Leprosy Immune Physiopathology.

Search more.